ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTER01

Development of Methods for a Simplified and Reliable Prostate Cancer MRI Exam

Active
Institution
BRIGHAM AND WOMEN'S HOSPITAL, MA
Principal investigator
Stephan E Maier
Funding
$450K
Duration
2020–2026
Open portfolio

Moonbase score

Still being scored

Abstract

Abstract Non-invasive, multi-parametric characterization of prostate cancer (PC), with magnetic resonance imaging (MRI) methods, is an active area of research with great potential for providing improved diagnosis and treatment monitoring. The PI-RADSv2 assessment system that was established by an international team of experts recognizes the value of quantitative images in PC diagnosis, but relies largely on qualitative evaluation of weighted images. Although this grading approach achieves reasonably good separation be- tween normal and abnormal prostate tissue, it does not achieve adequate separation between indolent and aggressive disease, with the risk that more unnecessary and costly surgery is performed with poten- tially dire consequences on patient quality of life. High-value protocols, without need for an invasive and costly endo-rectal radio-frequency coil are being investigated. This comes at the cost of extended scan time and reduced image quality in terms of spatial resolution, signal-to-noise ratio and signal bias, which negatively impacts sensitivity and specificity of multi-parametric MRI. With the pronounced increase of multi-parametric MRI exams, there is also the desire to integrate the support by the most recent revolution in diagnostic imaging, i.e., machine learning. It becomes increasingly clear, that in order to avoid having to train neural networks for each specific system and protocol, reproducible and thus preferably quantitative imaging protocols are essential. To overcome these limitations, we propose both pulse sequence develop- ment, investigation of ADC validity and reproducibility and novel post-processing strategies. The overall objective is to demonstrate the added value of lesion characterization with quantitative values and at the same time understand and minimize the influence of protocol choices and scan hardware, hence improve overall reproducibility. Specific Aim 1 will focus on the development of a low distortion MR imaging sequence for rapid concurrent quantification of T2 and diffusion signal decay. Specific Aim 2 will examine ADC variations that result from changes in diffusion time over a range that is typical with present day clinical MR systems. Specific Aim 3 introduces advanced handling of low noise diffusion data, which will be indispensable for achieving high accuracy and precision with non-invasive and economic external coils. Specific Aim 4 introduces a novel ADC computation approach that fully captures the complex diffusion signal decays in tissues and at the same time is largely protocol and system independent. Moreover, re- sulting images and quantitative maps processed according this approach, exhibit considerably lower noise, which can be traded for higher spatial resolution or shorter scan duration. In combination, the consis- tently quantitative nature of the data and its ubiquitous validity and comparability will greatly facilitate the establishment of recommendations for disease-related thresholds. Ultimately this may permit much more reliable differentiation of aggressive from indolent disease.

LOADING MOONBASE SCORE

R01NATIONAL CANCER INSTITUTEEmerging Imaging Technologies and Applications Study Section[EITA]imagesprostateprostate cancerspatial resolutionscanmriadcindolent

Questions for BRIGHAM AND WOMEN'S HOSPITAL

Answered by the team behind this research.

Same institution, same topic, scored first.